Braeburn Pharmaceuticals
Princeton, US · Delaware corporation
Biotech
Founders & leadership
DJ
David J. McIntyreChief Financial Officer and Treasurer
MD
Michael DerkaczChief Executive Officer and President
AM
Asher M. RubinSecretary
Board
AK
Argeris Karabelas, Ph.D.Board director
SL
Seth L. Harrison, M.D.Chairman
DH
Dennis H. Langer, J. D., M.D.Board director
JB
Jeffrey BerkowitzBoard director
BM
Brian MarkisonBoard director
PK
Patrick KennedyBoard director
Reported raises · per SEC filings
Form D private placements$110M disclosed across 1 round · 2018
▶$110MraisedJan 2018 · 8 investors · BiotechnologyRule 506(b)
▶$110MraisedJan 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Dennis H. Langer, J. D., M.D.Director
- Jeffrey BerkowitzDirector
- David J. McIntyreExecutive Officer
- Asher M. RubinExecutive Officer
- Brian MarkisonDirector
- Argeris Karabelas, Ph.D.Director
- Patrick KennedyDirector
- Michael DerkaczExecutive Officer, Director
- Seth L. Harrison, M.D.Executive Officer, Director
- Offering amount
- $110M
- Amount sold
- $110M
- First sale
- Jan 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Braeburn Pharmaceuticals raised?
- Braeburn Pharmaceuticals has disclosed $110M raised across 1 round.
- Where is Braeburn Pharmaceuticals headquartered?
- Braeburn Pharmaceuticals is headquartered in Princeton, US.